Intrinsic InvestorIntrinsic Investor
DashboardStocksAI AnalystAITop IdeasCryptoScreenerWatchlistsPortfolio
SectorsHeatmapETFsMacro
SignalsPROPremium previewTrack recordBacktestDCF builderCompare
Paper tradingTrade historyAlertsConnect broker
Congress tradesEarningsCommunityLearn
Settings
⌘K
Log inSign up free
HomeStocksListsPortfolio
GILD Stock Price & Intrinsic Value | Intrinsic Investor
Back
GILD logo

Gilead Sciences, Inc. (GILD)

Biotechnology
GILD · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →
$125.59
−0.22%
Watch Compare
Price · 1 year
Watch+ Add to portfolio
Loading live analysis…
Loading analysis…

Intrinsic Investor is for education and research only — not financial advice.

Key metrics

EPS
$6.78
ROE
43.4%
Gross margin
79.4%
Debt/Equity
94.64
Revenue growth
4.4%

AI Valuation Narrative

Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.

Screen StocksLearn Intrinsic ValueTrading SignalsCompare Stocks

Explore more

More in Biotechnology →More in Drug Manufacturers - General →Stocks in US →Stocks on NASDAQ NMS - GLOBAL MARKET →Compare stocks side-by-side →

Peers & similar stocks

Quick links to related tickers for research.

AbbVie IncABBVAmgen Inc.AMGNVertex Pharmaceuticals IncorporVRTXRegeneron Pharmaceuticals, Inc.REGNAlnylam Pharmaceuticals IncALNYNatera IncNTRA

About Gilead Sciences, Inc.

 

Weekly undervalued picks (like GILD)

Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.

Free. No spam. We only email once per week.

Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.